Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SPECT Imaging of Brain Tumors Using Technetium-99m Labeled 1-Thio-D-Glucose (99mTc-1-thio-D-glucose).

NCT04288518 is registered in ClinicalTrials.gov with Tomsk National Research Medical Center of the Russian Academy of Sciences as lead sponsor.

NCT NCT04288518
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04288518 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SPECT Imaging of Brain Tumors Using Technetium-99m Labeled 1-Thio-D-Glucose (99mTc-1-thio-D-glucose).
Lead sponsor
Tomsk National Research Medical Center of the Russian Academy of Sciences
Phase
Phase 1/2
Overall status
Completed
Start date
February 15, 2020
Completion date
February 15, 2021
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain, neoplasms